Anahita Medicos Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 22-06-2024
- Paid Up Capital ₹ 3.75 Cr
as on 22-06-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.90 Cr
as on 22-06-2024
- Satisfied Charges ₹ 3.07 Cr
as on 22-06-2024
- Revenue %
(FY 2023)
- Profit -155.25%
(FY 2023)
- Ebitda -155.25%
(FY 2023)
- Net Worth 3.15%
(FY 2023)
- Total Assets 67.85%
(FY 2023)
About Anahita Medicos
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 3.75 Cr.
The company currently has active open charges totaling ₹7.90 Cr. The company has closed loans amounting to ₹3.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ritesh Gangwar, Shruti Rai, Saurabh Rai, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U74999UP2018PTC100834
- Company No.
100834
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anahita Medicos?
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Pandey  | Director | 07-Feb-2018 | Current |
| Ritesh Gangwar | Director | 17-May-2022 | Current |
| Shruti Rai | Director | 07-Feb-2018 | Current |
| Saurabh Rai | Director | 07-Feb-2018 | Current |
| Apeksha Vishnoi | Director | 08-Jul-2022 | Current |
| Roopali Sharma | Director | 28-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Anahita Medicos.
Anahita Medicos Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 155.25% decrease in profit. The company's net worth moved up by a moderate rise of 3.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anahita Medicos?
In 2023, Anahita Medicos had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Dec 2022 | ₹2.90 Cr | Open |
Others Creation Date: 30 Dec 2020 | ₹5.00 Cr | Open |
Tata Capital Housing Finance Limited Creation Date: 17 Jul 2019 | ₹3.07 Cr | Satisfied |
How Many Employees Work at Anahita Medicos?
Unlock and access historical data on people associated with Anahita Medicos, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anahita Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anahita Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
